Share buy-back week 11/2017

Udgivet den 20-03-2017  |  kl. 15:19  |  

Announcement             

20 March 2017 

Coloplast - transactions in connection with share buy-back programme

As mentioned in Announcement No. 2/2017 Coloplast has initiated the second part of the share buy-back programme totalling up to DKK 1bn. This part of the programme of DKK500m is expected to take place from 27 February, 2017 to 28 August, 2017.

The buy-back programme will be structured in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Regulation 2016/1052, also referred to as the Safe Harbour rules, which ensure that the company is protected against violation of insider legislation in connection with the buyback programme.

The following transactions have been executed during the period 13 - 17 March 2017:

Date Number of shares Buying price Amount DKK
13 March 2017 10,388 507.02 5,266,900.91
14 March 2017 13,500 506.22 6,834,018.60
15 March 2017 15,500 504.24 7,815,712.25
16 March 2017 11,324 506.05 5,730,481.89
17 March 2017 6,490 508.36 3,299,227.84
Accumulated until now under the programme 196,707 500.03 98,359,073.88

Henceforth, Coloplast owns 3,878,722 treasury B shares of DKK 1 equal to 1.80% of the company's total share capital.

An overview showing the transaction data for the period 13 - 17 March 2017 is enclosed.

Kind regards,

Investor Relations

Coloplast A/S

Tel. +45 4911 1800

   

For further information, please contact

Investors and analysts                                           

Ellen Bjurgert

Director, Investor Relations

Tel. +45 4911 1800/+45 4911 3376

Email: dkebj@coloplast.com

 

Rasmus Sørensen

Sr. Manager, Investor Relations

Tel. +45 4911 1800/ +45 4911 1786

Email: dkraso@coloplast.com

                                                                                       

Press and the media                                               

Maria Lindeberg

Sr. Media Relations Manager

Tel. 4911 3095

Email: dkmalg@coloplast.com

 

This announcement is available in a Danish and an English language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.

Our business includes ostomy care, urology and continence care and wound and skin care. We operate globally and employ more than 11,000 people.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2017-03 All rights reserved Coloplast A/S, 3050 Humlebæk, Denmark. 

Vedhæftede filer:

Sharebuyback_20032017.pdf

Transaction data_week11.pdf

Udgivet af: NPinvestordk

Seneste nyheder

17:46 Europa/aktier: Faldt fra rekordniveau anført af Siemens
17:09 Torsdagens obligationer: Status quo for renterne efter byge af nøgletal
17:04 Torsdagens aktier: Mærsk og Danske Bank trak C25 nærmere alle tiders rekord
16:53 Amerikansk indeks sætter rekord: Passerer psykologisk niveau for første gang
16:32 Mærsk-aktierne stiger efter nye kraftige ratestigninger
16:28 Novo ser ingen effekt på produktionen efter brand i Kalundborg
16:00 Bidens toprådgiver forsvarer nye toldsatser på kinesiske varer
15:42 USA/åbning: Rekordjagten fortsætter anført af Walmart og Chubb
15:23 Novo-aktien sendes i svingninger efter nyt om brand på byggeplads i Kalundborg
15:14 Valuta: Dollar finder fodfæste efter tre dage med svækkelse
15:00 Novo-rival har positive data med ugentligt insulin
14:54 Novo-aktien sendes i svingninger efter nyt om brand på byggeplads i Kalundborg
14:35 Novo-aktien sendes i svingninger efter nyt om brand på byggeplads i Kalundborg
14:32 USA: Lidt flere nytilmeldte ledige end ventet
14:27 North Media forventer mindre overskud på grund af udgifter til svensk opkøb
13:43 USA/tendens: Rekordjagt kan fortsætte efter solide præstationer fra Walmart og Cisco
13:18 Europa/aktier: Let sivende aktier efter ni dage med fremgang til rekord
12:24 Obligationer/middag: Rentestabilisering før byge af amerikanske nøgletal
11:48 Aktier/middag: Vestas trækker op og Zealand Pharma ned i tæt på fladt marked
11:29 Novo-rival har imponerende fedmedata: Men for tidligt at bekymre sig vurderer storbank